Search site
-
-
-
-
-
-
The 10 most recent posts
- Why children with Down syndrome have higher leukemia risk
- Circadian rhythms and sudden cardiac death: first definitive link
- How corporate wellness programs beat rising healthcare costs: new white paper
- Which ear you hold your cell phone to tells what kind of thinker you are
- Osteoporosis: serotonergic drugs may provide novel opportunities for therapeutic interventions
- HIV, Hep C drug interactions subject of European Medicines Agency alert
- Ovarian cancer treatment breakthrough at Penn State
- How stress ages cells and, therefore, us: new research
- Schizophrenia neural impairments may not be immutably fixed
- Pre-pregnancy micronutrient exposure associated with gene modifications in offspring; potentially large impact on developing nation public health
- This site does not provide medical advice, diagnosis or treatment.
-
-
-
-
Category Archives: Diabetes
Highly unlikely that impaired glucose or associated metabolic derangements cause polyneuropathy
ROCHESTER, Minn.–(BUSINESS WIRE)–In a reversal of two decades of medical reports, a Mayo Clinic study finds the frequency of nerve damage called diabetic polyneuropathy is similar in prediabetic patients and healthy people. Physicians should seek explanations other than prediabetes for … Continue reading
Posted in Diabetes, Neuropathy
Comments Off
Diabetes incidence rising: Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets(http://www.researchandmarkets.com/research/54a0f2/blood_glucose_test) has announced the addition of the “Blood Glucose Testing and Diabetes Management” report to their offering. There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity … Continue reading
Posted in Diabetes
Comments Off
Insulin production may persist for decades after the onset of type 1 diabetes: MGH study
The Diabetes Page on Amazon Massachusetts General Hospital (MGH) research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent … Continue reading
Posted in Diabetes, Diabetes: Type 1
Comments Off
EU approval of Byetta use with basal insulin
SAN DIEGO and INDIANAPOLIS, Feb. 17, 2012 /PRNewswire/ — Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has … Continue reading
Posted in Diabetes
Comments Off